516 related articles for article (PubMed ID: 27965088)
1. Lanthionine ketimine ester promotes locomotor recovery after spinal cord injury by reducing neuroinflammation and promoting axon growth.
Kotaka K; Nagai J; Hensley K; Ohshima T
Biochem Biophys Res Commun; 2017 Jan; 483(1):759-764. PubMed ID: 27965088
[TBL] [Abstract][Full Text] [Related]
2. Lanthionine ketimine ester provides benefit in a mouse model of multiple sclerosis.
Dupree JL; Polak PE; Hensley K; Pelligrino D; Feinstein DL
J Neurochem; 2015 Jul; 134(2):302-14. PubMed ID: 25846048
[TBL] [Abstract][Full Text] [Related]
3. Lanthionine ketimine ethyl ester partially rescues neurodevelopmental defects in unc-33 (DPYSL2/CRMP2) mutants.
Hubbard C; Benda E; Hardin T; Baxter T; St John E; O'Brien S; Hensley K; Holgado AM
J Neurosci Res; 2013 Sep; 91(9):1183-90. PubMed ID: 23825043
[TBL] [Abstract][Full Text] [Related]
4. An Agonist of the Protective Factor SIRT1 Improves Functional Recovery and Promotes Neuronal Survival by Attenuating Inflammation after Spinal Cord Injury.
Chen H; Ji H; Zhang M; Liu Z; Lao L; Deng C; Chen J; Zhong G
J Neurosci; 2017 Mar; 37(11):2916-2930. PubMed ID: 28193684
[TBL] [Abstract][Full Text] [Related]
5. A re-assessment of the effects of treatment with a non-steroidal anti-inflammatory (ibuprofen) on promoting axon regeneration via RhoA inhibition after spinal cord injury.
Sharp KG; Yee KM; Stiles TL; Aguilar RM; Steward O
Exp Neurol; 2013 Oct; 248():321-37. PubMed ID: 23830951
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glial proliferation, promotion of axonal growth and myelin production by synthetic glycolipid: A new approach for spinal cord injury treatment.
García-Álvarez I; Fernández-Mayoralas A; Moreno-Lillo S; Sánchez-Sierra M; Nieto-Sampedro M; Doncel-Pérez E
Restor Neurol Neurosci; 2015; 33(6):895-910. PubMed ID: 26484699
[TBL] [Abstract][Full Text] [Related]
7. Blockade of IL-6 signaling by MR16-1 inhibits reduction of docosahexaenoic acid-containing phosphatidylcholine levels in a mouse model of spinal cord injury.
Arima H; Hanada M; Hayasaka T; Masaki N; Omura T; Xu D; Hasegawa T; Togawa D; Yamato Y; Kobayashi S; Yasuda T; Matsuyama Y; Setou M
Neuroscience; 2014 Jun; 269():1-10. PubMed ID: 24657456
[TBL] [Abstract][Full Text] [Related]
8. Tegaserod, a small compound mimetic of polysialic acid, promotes functional recovery after spinal cord injury in mice.
Pan HC; Shen YQ; Loers G; Jakovcevski I; Schachner M
Neuroscience; 2014 Sep; 277():356-66. PubMed ID: 25014876
[TBL] [Abstract][Full Text] [Related]
9. Two-photon-excited fluorescence microscopy as a tool to investigate the efficacy of methylprednisolone in a mouse spinal cord injury model.
Zhang Y; Zhang L; Shen J; Chen C; Mao Z; Li W; Gan WB; Tang P
Spine (Phila Pa 1976); 2014 Apr; 39(8):E493-9. PubMed ID: 24480947
[TBL] [Abstract][Full Text] [Related]
10. In vivo two-photon imaging reveals a role of progesterone in reducing axonal dieback after spinal cord injury in mice.
Yang Z; Xie W; Ju F; Khan A; Zhang S
Neuropharmacology; 2017 Apr; 116():30-37. PubMed ID: 27965141
[TBL] [Abstract][Full Text] [Related]
11. A derivative of the CRMP2 binding compound lanthionine ketimine provides neuroprotection in a mouse model of cerebral ischemia.
Nada SE; Tulsulkar J; Raghavan A; Hensley K; Shah ZA
Neurochem Int; 2012 Dec; 61(8):1357-63. PubMed ID: 23036362
[TBL] [Abstract][Full Text] [Related]
12. Functional Recovery of Carbon Nanotube/Nafion Nanocomposite in Rat Model of Spinal Cord Injury.
Imani S; Zagari Z; Rezaei Zarchi S; Jorjani M; Nasri S
Artif Cells Nanomed Biotechnol; 2016; 44(1):144-9. PubMed ID: 25861814
[TBL] [Abstract][Full Text] [Related]
13. Low-dose fractionated irradiation promotes axonal regeneration beyond reactive gliosis and facilitates locomotor function recovery after spinal cord injury in beagle dogs.
Zhang Q; Xiong Y; Zhu B; Zhu B; Tian D; Wang W
Eur J Neurosci; 2017 Nov; 46(9):2507-2518. PubMed ID: 28921700
[TBL] [Abstract][Full Text] [Related]
14. Isorhamnetin promotes functional recovery in rats with spinal cord injury by abating oxidative stress and modulating M2 macrophages/microglia polarization.
Chen F; Hu M; Shen Y; Zhu W; Cao A; Ni B; Qian J; Yang J
Eur J Pharmacol; 2021 Mar; 895():173878. PubMed ID: 33453223
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.
Jeong SJ; Cooper JG; Ifergan I; McGuire TL; Xu D; Hunter Z; Sharma S; McCarthy D; Miller SD; Kessler JA
Neurobiol Dis; 2017 Dec; 108():73-82. PubMed ID: 28823935
[TBL] [Abstract][Full Text] [Related]
16. Salidroside attenuates neuroinflammation and improves functional recovery after spinal cord injury through microglia polarization regulation.
Wang C; Wang Q; Lou Y; Xu J; Feng Z; Chen Y; Tang Q; Zheng G; Zhang Z; Wu Y; Tian N; Zhou Y; Xu H; Zhang X
J Cell Mol Med; 2018 Feb; 22(2):1148-1166. PubMed ID: 29148269
[TBL] [Abstract][Full Text] [Related]
17. Delayed granulocyte colony-stimulating factor treatment promotes functional recovery in rats with severe contusive spinal cord injury.
Lee JS; Yang CC; Kuo YM; Sze CI; Hsu JY; Huang YH; Tzeng SF; Tsai CL; Chen HH; Jou IM
Spine (Phila Pa 1976); 2012 Jan; 37(1):10-7. PubMed ID: 22024901
[TBL] [Abstract][Full Text] [Related]
18. Complement C5a is detrimental to histological and functional locomotor recovery after spinal cord injury in mice.
Li L; Xiong ZY; Qian ZM; Zhao TZ; Feng H; Hu S; Hu R; Ke Y; Lin J
Neurobiol Dis; 2014 Jun; 66():74-82. PubMed ID: 24607885
[TBL] [Abstract][Full Text] [Related]
19. Administration of low dose estrogen attenuates persistent inflammation, promotes angiogenesis, and improves locomotor function following chronic spinal cord injury in rats.
Samantaray S; Das A; Matzelle DC; Yu SP; Wei L; Varma A; Ray SK; Banik NL
J Neurochem; 2016 May; 137(4):604-17. PubMed ID: 26998684
[TBL] [Abstract][Full Text] [Related]
20. Proteomic identification of binding partners for the brain metabolite lanthionine ketimine (LK) and documentation of LK effects on microglia and motoneuron cell cultures.
Hensley K; Christov A; Kamat S; Zhang XC; Jackson KW; Snow S; Post J
J Neurosci; 2010 Feb; 30(8):2979-88. PubMed ID: 20181595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
